Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07206602 · ClinicalTrials.gov registry record · NA

AI-Guided Left Bundle Branch Area Pacing

A NA study of Heart Failure, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
224
Enrollment target
1
Study location

NCT07206602: Recruiting NA study of Heart Failure, sponsored by Mayo Clinic.

NCT07206602 is a NA study of Heart Failure that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 224 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT07206602, a NA study of Heart Failure, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
224 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the effectiveness of AI-guided LBBAP versus conventional LBBAP (not AI-guided) in improving CRT response rates and clinical outcomes.

Primary Outcome

CRT response is defined as an absolute increase of \>5% in left ventricular ejection fraction (LVEF) after 6 months of CRT

Conditions Studied

Interventions

  • DEVICE AI-assisted Left Bundle Branch Area Pacing
  • PROCEDURE Left Bundle Branch Area Pacing

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2026-01-23
Est. Completion 2027-11
Phase NA
Mayo Clinic

2,844 total trials

What NCT07206602 shows while recruiting

NCT07206602 is an interventional study that assigns participants to a tested intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which AI-assisted Left Bundle Branch Area Pacing is the first listed.

NCT07206602 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT07206602 about?

NCT07206602 is a clinical study titled "AI-Guided Left Bundle Branch Area Pacing". The purpose of this study is to compare the effectiveness of AI-guided LBBAP versus conventional LBBAP (not AI-guided) in improving CRT response rates and clinical outcomes.

What is the current status of trial NCT07206602?

This trial is currently recruiting. It is a NA study. The enrollment target is 224 participants. The study started on 2026-01-23. Estimated completion is 2027-11.

What conditions does trial NCT07206602 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT07206602?

The interventions under investigation include: AI-assisted Left Bundle Branch Area Pacing (DEVICE), Left Bundle Branch Area Pacing (PROCEDURE).

Who is sponsoring clinical trial NCT07206602?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07206602 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07206602's enrollment target sits among peer trials

224 157th of 397 higher than 241 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02706561 · 224 participants · NA

    Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

  • NCT04140344 · 224 participants · NA

    The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions

  • NCT04915183 · 224 participants · Phase 2

    Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

  • NCT05519878 · 224 participants · NA

    Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07206602, the US trial registry maintained by the National Library of Medicine. NCT07206602 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.